Lack of effect of concomitant zidovudine on rifabutin kinetics in patients with AIDS-related complex

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1397-1402

  Li, Ronald C ^a,b   Nightingale, Stephen ^c   Lewis, Richard C ^a   Colborn, David C ^a   Narang, Prem K ^a  

^a PFIZER INC   (United States)

^b Prince of Wales Hospital   (Hong Kong)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENTAMIDINE; RIFABUTIN; ZIDOVUDINE;

ADULT; AIDS RELATED COMPLEX; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISPOSITION; DRUG MIXTURE; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029934279     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1397     Document Type: Article

References (23)

1. Battaglia, R., E. Pianezzola, G. Salgarollo, G. Zini, and M. Strolin Benedetti. 1990. Absorption, disposition and preliminary metabolic pathway of 14C-rifabutin in animals and man. J. Antimicrob. Chemother. 26:813-822.
2. Berson, A., K. Happy, F. Rousseau, G. Grateau, R. Farinotti, and D. Séréni. 1993. Effect of zidovudine (AZT) on cotrimoxazole (TMP-SMX) kinetics. preliminary results, abstr. PO-B30-2193 Presented at the 12th International Conference on AIDS, Berlin. 6 to 11 June 1993.
3. Burger, D. M., P. L. Meerhorst, C. H. W. Koks, and J. H. Beijnen. 1993. Pharmacokmetic interaction between rifampin and zidovudine. Antimicrob. Agents Chemother. 37:1426-1431
4. Chatton, J. Y., A. Munafo, J. P. Chave, F. Steinhȧuslin, F. Roch-Ramel, M. P. Glauser, and J. Biollaz. 1992. Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide. Br. J. Clin. Pharmacol. 34:551-554.
5. De Miranda, P., S. S. Good, R. Yarchoan, R. V. Thomas, M. R. Blum, C. E. Myers, and S. Broder. 1989. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. Clin. Pharmacol. Ther. 46:494-500
6. Fischl, M. A., D. D. Richman, N. Hansen, A. C. Collier, J. T. Carey, M. F. Para, D. Hardy, R. Dolin, W. G. Powderly, J. D. Allan, B. Wong, T. C. Merigan, V. J. McAuliffe, N. E. Hyslop, F. S. Rhame, II. II. Balfour, Jr., S. A. Spector, P. Volberding, C. Pettinelli, J. Andersen, and The AIDS Clinical Research Group. 1990. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. Ann. Intern. Med. 112:727-737
7. Gibaldi, M., and D. Perrier. 1982. Noncompartmental analysis based on statistical moment theory, p. 409-416. In J. Swarbrick (ed.), Pharmacokinetics, 2nd ed. Marcel Dekker, Inc., New York.
8. Good, S. S., and P. de Miranda. 1992. Species differences in the metabolism and disposition of antiviral nucleoside analogues. 2. Zidovudine. Antivir. Chem. Chemother. 3:65-77.
9. Heifets, L. B., M. D. Iseman, and P. J. Lindholm-Levy. 1985. Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods. Antimicrob Agents Chemother 28: 570-575.
10. Lewis, R. C., N. Z. Hatfield, and P. K. Narang. 1991 A sensitive method for quantitation of rifabutin and its desacetyl metabolite in human biological fluids by high-performance liquid chromatography (HPLC). Pharmacol. Res. 8:1434-1440.
11. Masur, H. 1993. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus. N. Engl. J. Med 329:898-904
12. Morse, G. D., M. J. Shelton, and O'Donnell. 1993. Comparative pharmacokinetics of antiviral nucleoside analogues Clin. Pharmacokinet 24:101-123.
13. Narang, P., S. Nightingale, C. Manzone, D. Colborn, B. Wynne, R. Li, D. Watson, N. Barris, T. Blaschke, and J. R. Bianchine. 1992 Does rifabutin (RBT) affect zidovudine (ZDV) disposition in HIV (+) patients? Abstr 3888 In Program of Abstracts of the 8th International Conference on AIDS/ 3rd Sexually Transmitted Diseases World Congress.
14. Narang, P. K., C. B. Trapnell, J. Schoenfelder, J. P. Lavelle, and J. R. Bianchine. 1994 Fluconazole and enhanced effect of rifabutin prophylaxis N. Engl. J Med. 330:1316
15. Nightingale, S. D., D. W. Cameron, F. M. Gordin, P. M. Sullam, D. L. Cohn, R. E. Chaisson, L. J. Eron, P. D. Sparti, B. Bihari, D. L. Kaufman, J. J. Stern, D. D. Pearce, W. G. Weinberg, A. LaMarca, and F. P. Siegal. 1993. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N. Engl. J. Med. 329:828-833.
16. Nordic Medical Research Council HIV Therapy Group. 1992 Br. Med. J 304:13-17.
17. Physicians' Desk Reference. 1993. Retrovir® (zidovudine), package insert 822. Medical Economics Company, Montvale, NJ.
18. Schwartz, E. L., A.-B. Brechbühl, P. Kahl, M. A. Miller, P. A. Selwyn, and G. H. Friedland. 1992. Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection. J. Acquired Immune Defic. Syndr. 5:619-626.
19. Skinner, M. H., M. Hsieh, J. Torseth, D. Pauloin, G. Bhatia, S. Harkonen, T. C. Merigan, and T. F. Blaschke. 1989. Pharmacokinetics of rifabutin. Antimicrob. Agents Chemother. 33:1237-1241.
20. Strolin-Benedetti, M., C. Efthymiopoulos, D. Sassella, E. Moro, and M. Repetto. 1990. Autoinduction of rifabutin metabolism in man Xenobiotica 20:1113-1119.
21. Tamassia, V. 1986. A dose proportionality study of rifabutin in healthy volunteers given single oral doses (300, 450, and 600 mg). Internal report LM 427/610i. Farmitalia Carlo Erba, Italy.
22. Ungheri, D., G. Franceschi, and C. Della Bruna. 1986. Main human urinary metabolites of the spiropiperidyl rifamycin LM 427: isolation and biological properties, p. 1917-1918. In J Ishigami (ed.). Recent advances in chemotherapy: proceedings of the 14th International Congress of Chemotherapy, Kyoto, 1985. University of Tokyo Press, Tokyo.
23. Wilde, M. I., and H. D. Langtry. 1993. Zidovudine: an update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy Drugs 46:515-578.